Cargando…
Donor-Derived Cell-Free DNA (ddcf-DNA) and Acute Antibody-Mediated Rejection in Kidney Transplantation
Monitoring kidney transplant recipients for evidence of allograft rejection is essential to lower the risk of graft loss. The traditional method relies on serial checks in serum creatinine with a biopsy of the allograft if dysfunction is suspected. This is invasive, labor-intensive and costly. As su...
Autores principales: | Jaikaransingh, Vishal, Kadambi, Pradeep V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147225/ https://www.ncbi.nlm.nih.gov/pubmed/34062714 http://dx.doi.org/10.3390/medicina57050436 |
Ejemplares similares
-
Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018) -
Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022) -
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
por: Hurkmans, Daan P., et al.
Publicado: (2019) -
Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023) -
Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation
por: Keller, Michael, et al.
Publicado: (2021)